ALIM : Summary for Alimera Sciences, Inc. - Yahoo Finance

U.S. Markets closed

Alimera Sciences, Inc. (ALIM)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.16+0.01 (+0.87%)
At close: 4:00 PM EST
People also watch:
PSDVACRXANTHAEGRCCXI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.15
Open1.14
Bid1.01 x 500
Ask1.55 x 400
Day's Range1.12 - 1.16
52 Week Range1.01 - 5.15
Volume230,562
Avg. Volume270,575
Market Cap75.24M
Beta2.54
PE Ratio (TTM)-1.46
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube5 days ago

    ETFs with exposure to Alimera Sciences, Inc. : December 6, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube27 days ago

    ETFs with exposure to Alimera Sciences, Inc. : November 14, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
    Capital Cubelast month

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016

    Categories: Yahoo Finance Get free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Insmed Incorporated and Aerie Pharmaceuticals, Inc. (INSM-US and AERI-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 8.30 million, ... Read more (Read more...)